The reaction of tert-butyl 4-oxopiperidine-1-carboxylate dimethylhydrazone with BuLi and further with iodides of protected alcohols ICH 2 (CH 2 ) n OSiMe 2 (t-Bu) (n = 1-4) led to the formation of the corresponding tert-butyl 3-{[tert-butyl(dimethyl)silyl]alkyl}-4-oxopiperidine-1-carboxylates that under the treatment with triethylsilane in the presence of anhydrous BiBr 3 underwent cyclization with a high stereoselectivity into cis-isomers of N-Boc piperidine derivatives [3,2-c]-fused with oxygen heterocycles. The latter at the treatment with anhydrous HCl eliminate the Boc group affording hydrochlorides of stereochemically homogeneous N-unsubstituted fused bicyclic systems.Among the most important fields of modern organic chemistry the stereoregular synthesis should be mentioned of substances containing pharmacophore fragments of naturally occurring compounds [1, 2] that may possess a high biological activity. Among such fragments piperidine derivatives and oxygen heterocycles are often found [3], thus stimulating the research on these classes of compounds.In extension of research [4,5] on the synthesis of piperidine derivatives containing tetrahydrofuran rings we developed in this study a general stereoselective procedure for the synthesis of oxygen heterocycles [3,2-c]-fused with the piperidine ring. The protocol of the synthesis consisted in the reaction of tert-butyl 4-oxopiperidine-1-carboxylate dimethylhydrazone (I) with available [6-13] iodides of protected alcohols IIа-IId analogously to the concisely described procedure [14] (Scheme 1).In contrast to dimethylhydrazone I we failed to alkylate N-Boc-4-oxopiperidine with the formation of target products III and IV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.